Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Wugen is dedicated to developing off-the-shelf cell therapies for treatment of cancer These cell therapy drugs originate from healthy donors and are amplified in order to enhance cancer cell elimination. Our Immuno-Oncology therapies address the needs of patients with solid tumors, acute myeloid leukemia (AML), multiple myeloma (MM) and T-cell malignancies.

List your booth number for exhibitions, ask us